Outgoing CEO Kevin Sayer expects expanding coverage of Dexcom’s glucose sensors for people with Type 2 diabetes and ...

Jake Leach will take over the role at the start of 2026, with Sayer remaining chairman of the board after the transition.

Dexcom is recalling certain Dexcom G6, G7, ONE, and ONE+ glucose monitoring receivers because of a problem with the speaker that may cause it to fail to make an alert sound when blood sugar is dangero ...

FDA issues warning letters to distributors of food, dietary supplements and unapproved drugs that contain 7-hydroxymitragynine (7-OH) and advises consumers that these products pose significant dangers ...

A recall of multiple ice cream products in 23 states has been issued the second highest risk warning by the Food and Drug Administration (FDA).

The FDA is reevaluating longtime warnings on hormone replacement therapy products for menopausal women. Some advocates for change say the so-called “black box” that lists health risks is ...

The Florida Department of Environmental Protection has issued a warning letter to a Sebastian landowner, a Vero Beach land-clearing company and a Florida Department of Transportation official for ...

FDA recalls Dexcom glucose monitors (G6, G7, ONE models) due to alert issues posing severe health risks. Read more here.

The FDA is reconsidering the black box warning on estrogen. Experts say it’s time for a change—find out what this means for hormone therapy and your health.

Prestige Consumer Healthcare Inc. issued a voluntary recall for more than 10,000 cases of honey cough syrup on June 17.

The letters instruct the companies to cease the illegal marketing of products containing added 7-OH or that have elevated levels of 7-OH.